Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis.

21Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Depression and anxiety have been reported in patients with multiple sclerosis (MS) and in patients with clinically isolated syndrome (CIS). However, the precise mechanisms that lead to depressive and anxiety symptoms in these patients are still unclear. In this study we evaluated with the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) patients with MS and CIS and compared them to controls. We also correlated BDI and BAI scores with clinical parameters. Kruskall-Wallis followed by Dunn's Multiple Comparison Test, Chi-square and Spearman test were used. Patients with MS had higher depressive and anxiety scores than controls. The BDI and BAI scores of patients with CIS were not significantly different from controls. There was a positive correlation between BDI, BAI and EDSS. Our results corroborate the view that MS patients have higher depression and anxiety levels than control subjects. Anxiety and depressive symptoms also seem to progress according to the severity of the disease.

Cite

CITATION STYLE

APA

Anhoque, C. F., Domingues, S. C. A., Carvalho, T., Teixeira, A. L., & Domingues, R. B. (2011). Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis. Arquivos de Neuro-Psiquiatria, 69(6), 882–886. https://doi.org/10.1590/s0004-282x2011000700006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free